Exposure to plants and nature is said to make humans calmer and more productive, and just feel better overall. That theory will be put to test inside a sprawling new… Read More
Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares at $12.50 and raising $80 million. It originally planned to sell 4.5 million shares… Read More
Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review “stemming from doctoral research Dr. Kawas conducted while at Washington… Read More
What’s $3 million divided by 347? That’s the math problem to be solved by the physicists on the Event Horizon Telescope team, who won one of the top awards in… Read More
As it closes in on one of the most valuable land deals in Seattle history, Alexandria Real Estate Equities is betting that biotech can thrive in a real estate market… Read More
One of the last big chunks of land in the booming Seattle neighborhood of South Lake Union will turn into a life sciences hub — with proceeds of the sale… Read More
Adaptive Biotechnologies is charting a massive expansion of its Seattle headquarters following the completion of a recent initial public offering. The company signed a 100,000 square-foot lease, tripling its current… Read More
Seattle is the top emerging life sciences hub in the U.S., according to a recent report from commercial real estate firm CBRE. That’s welcome news for an industry that has… Read More
If you see a lot of blue lights around Seattle landmarks this week, it’s not in honor of the Seahawks — this time, the color scheme is paying tribute to another… Read More
A big new project near Amazon’s Seattle headquarters could provide some relief to biotech and life sciences companies searching the city for office and lab space. Called Dexter Yard, the… Read More
More than 125,000 people receive an organ transplant every year. The procedure could replace a failing heart, lungs or kidneys, or even help recipients see for the first time in their… Read More
Bacteria lurk pretty much anywhere you look, in numbers and varieties worthy of a horror movie. The challenge for scientists who actually want to pry into these dark corners, packed… Read More
SAN FRANCISCO — Can artificial intelligence help battle malaria and other infectious diseases? Intellectual Ventures CEO Nathan Myhrvold says it’s time for his company’s AI-enabled microscope to join the fray. “We’ve… Read More
The U.S. healthcare system faces a myriad of challenges today, including uncertainty over federal regulation and shifting payer systems. You might expect that environment to give pause to many investors.… Read More
Washington State’s life sciences sector has historically been strong, even among the best in the nation. Industries like medicine, research and agriculture are right up there with aerospace, shipbuilding and… Read More
How do we understand science? That’s the question posed by the Institute for Systems Biology’s annual event, Consilience, and this year’s event will give Seattle science geeks a chance to experience… Read More
If you were handed a check for $200 million, what would you invest it in? Two Seattle investors, both with close ties to philanthropists Bill and Melinda Gates, will soon face… Read More
Washington state is a leader in many areas of science, technology, and innovation. But over the past few years, the state’s life science industry — once among its strongest —… Read More
A program that’s richer than the Nobels rewarded more than a dozen researchers tonight with Breakthrough Prize awards amounting to $25.4 million in all. The Breakthrough Prize program was founded in… Read More
Washington state’s life sciences sector experienced a huge boom in the early 2000s, even thriving during the great recession. But in recent past years, that growth has been waning. Some… Read More
Seattle boasts the fifth strongest life sciences market in the country, according to a new report from Jones Lang LaSalle, led by world-renowned institutions and startups that have grown to… Read More
“Mr. Gates, I Quit.” That’s the opening chapter of “Hood: Trailblazer of the Genomics Age,” and it’s just the first indication that this is no run-of-the-mill biography. In documenting the life and… Read More
Life Science Washington, the trade association formerly known as the Washington Biotechnology & Biomedical Association, has named Leslie M. Alexandre as its new president and CEO. She replaces Chris Rivera, who… Read More
Prevencio is looking to raise a total of $20 million in venture funding in the coming months to continue developing new patent-pending blood tests that accurately diagnose coronary artery disease and… Read More
It’s a bleak time on Wall Street, at least if you’re trying to take your company public. Just six venture-backed companies — all of them in the life sciences and… Read More
Frazier Healthcare Partners has raised a $525 million buyout fund that the Seattle venture capital firm will use to purchase profitable healthcare companies. “This fundraising allows us to continue our… Read More
Adaptive Biotechnologies, the heavily-funded Seattle bioinformatics company, today announced that Diego Miralles will become the president of a new division of the company called Adaptive Therapeutics. Miralles will work to build out the… Read More
The University of Washington held its first annual Health Innovation Challenge (HIC) Thursday—bringing innovators in entrepreneurship, business and health science together with students from regional universities. The challenge was a… Read More
NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join pharmaceutical… Read More
The Washington state legislature is looking at reviving two expired high-tech research-and development tax breaks — minus the previous exemptions for advanced computing and some electronic device technology. The previous… Read More